Clinical Trial

Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial is a prospective, multicenter, non-blinded, non-randomized study designed to assess the RelayPro thoracic endografts in the treatment of acute, complicated type B aortic dissection. The primary endpoint will measure all-cause mortality at 30 days post-procedure.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-01-25; most recent amendment 2025-11-05.
Status change: Recruiting → Active, Not Recruiting 2022-07-25
Status change: Not Yet Recruiting → Recruiting 2018-02-22
Trial Details
NCT Number NCT03033043
Lead Sponsor Bolton Medical
Conditions Aortic Dissection Type B
Enrollment 56 participants
Start Date 2017-12-14
Primary Completion 2021-10-31 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-11-06